Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Number of shares and voting rights as at 30 April 2014



Number of shares and voting rights

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF - Autorité des Marchés Financiers)


 


Press release

Avignon, May 14th, 2014


 




30.04.2014


























Total number of outstanding shares forming the capital

- 7,852,055 ordinary shares under ISIN FR0000054694

- 2,534 shares issued from stock-options under ISIN FR0000054694
7,854,589
Number of shares with double voting rights 851,442
Total number of gross voting rights 8,706,031
Number of shares without voting rights

- 6,476 bearer shares in the frame of the liquidity contract
- 6,476
Total number of exercisable voting rights* 8,699,555

*Real number of voting rights = total number of voting rights - number of shares without voting rights


 


If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com



  • Financial schedule







    - Q1 2014 results:

    - 2014 H1 sales

    - 2014 first-half results

    - 2014 third-quarter sales

    - 2014 third-quarter results

    - Annual revenue

    - Annual results
    26 May 2014

    25 July 2014

    29 August 2014

    4 November 2014

    28 November 2014

    3 February 2015

    31 March 2015



  • Upcoming events







    - AGM 26 June 2014


 


Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B






NATUREX Total number of shares comprising the share capital: 7,854,589

ISIN FR0000054694



NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD).



SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

 


About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs more than 1,450 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.


 



  • Contacts











Thierry Lambert

Chair and Chief Executive Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]

 

 
Thierry-Bertrand Lambert

Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]

 

 
Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-35946-cp-naturex_140514.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Share

Comments